GREY:DGCRF - Post by User
Post by
CUR2004on Nov 18, 2011 10:08am
245 Views
Post# 19248320
New study to guide initial biopsy decisions
New study to guide initial biopsy decisionsBeyond the Abstract - Clinical Evaluation of the PCA3 Assay in Guiding Initial Biopsy Decisions , by Alexandre de la Taille, MD., Et Al.
BERKELEY, CA (UroToday.com) - This prospective, open-label, multi-centre European study evaluated the clinical utility of the PROGENSATM PCA3 (Prostate CAncer gene 3) Assay in guiding initial prostate biopsy decisions in men with suspicion of prostate cancer (PCa). Briefly, the results show that the PCA3 Score improves the prediction of initial prostate biopsy outcomes in these men and may be suggestive of PCa aggressiveness.
https://www.urotoday.com/prostate-cancer-1014/beyond-the-abstract-clinical-evaluation-of-the-pca3-assay-in-guiding-initial-biopsy-decisions-by-alexandre-de-la-taille-md-et-al.html